Richard Paulson - Sep 8, 2022 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
President and CEO, Director
Signature
/s/ Nancy Smith as Attorney-in-Fact for Richard Paulson
Stock symbol
KPTI
Transactions as of
Sep 8, 2022
Transactions value $
-$18,196
Form type
4
Date filed
9/9/2022, 08:17 AM
Previous filing
Aug 5, 2022
Next filing
Oct 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale -$84 -16 0% $5.26 626K Sep 8, 2022 Direct F1
transaction KPTI Common Stock Sale -$18.1K -3.46K -0.55% $5.23 623K Sep 8, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.